BNC Share Price

Open 22.42 Change Price %
High 22.42 1 Day 0.07 0.31
Low 22.33 1 Week 0.00 0.00
Close 22.33 1 Month -0.42 -1.85
Volume 30 1 Year 22.12 10533.33
52 Week High 22.75
52 Week Low 20.15
BNC Important Levels
Resistance 2 22.41
Resistance 1 22.38
Pivot 22.36
Support 1 22.28
Support 2 22.25
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
ENB 54.20 -0.99%
ENB 54.20 -0.99%
ENB 54.20 -0.99%
ENB 54.20 -0.99%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
BBD-B 2.40 -4.76%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
I 3.40 21.00%
GEN 0.35 16.67%
GEN 0.35 16.67%
CUM 0.90 13.92%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
RKN 0.99 -17.50%
RKN 0.99 -17.50%
IMP 0.10 -16.67%
IMP 0.10 -16.67%
IMP 0.10 -16.67%
GCL 1.26 -13.70%
GCL 1.26 -13.70%
GCL 1.26 -13.70%
ANX 0.07 -12.50%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 2nd Feb 2017 BNC Share Price closed @ 22.33 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.43 & Strong Buy for SHORT-TERM with Stoploss of 5.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for February
1st Target up-side 22.98
2nd Target up-side 23.15
3rd Target up-side 23.31
1st Target down-side 22.52
2nd Target down-side 22.35
3rd Target down-side 22.19
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
BNC Latest News
There's more to the RRSP than mutual funds and ETFs, but you have to tread ...   Financial Post   - 17th Feb 17
The Canadian Covenant   Investing Daily   - 11th Feb 17
3 Bulletproof ETFs For Income In 2017   Forbes   - 02nd Feb 17
TSX listed corporate dividends and distributions declared Jan. 24   Brandon Sun   - 25th Jan 17
Purpose Investments Inc. Announces January Distributions   Marketwired (press release)   - 21st Jan 17
The No-Fee ETF Portfolio Beats the Pros   The Motley Fool Canada   - 27th Dec 16
Purpose Investments Inc. Anticipates No Special Distributions on all ETFs and ...   MarketWatch   - 01st Dec 16
Purpose Investments Announces the Launch of Two Innovative Income Funds   Marketwired (press release)   - 26th Oct 16
Is my ETF's yield too good to be true?   The Globe and Mail   - 15th Oct 16
Still puzzled by return of capital? Your questions answered   The Globe and Mail   - 26th Mar 16
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.